Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.
Copper Cu-64 PSMA I&T PET Imaging in Men with Newly Diagnosed Prostate Cancer (Solar-Stage)
Phase 3
Last update: August 14
Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Phase 1
Cabazitaxel +/- Carboplatin vs Lu-177-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer (CATCH-177)
Phase 2
Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer
Lu-177-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
Last update: August 13
Testing Lutetium Lu-177 Dotatate in Patients with Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
Comparing the Radiopharmaceutical Drug, [Lu-177]Lu-DOTATATE, to Standard of Care Treatment for Patients with Meningioma That Has Come Back After Prior Treatment (MOMENTUM-1)
Streamlined Resin Y90 Radiation Segmentectomy for Small HCC (One&Done)
N/A
SIRT with Tremelimumab and Durvalumab for Resectable HCC
Lu-177-DOTATATE (Lutathera) in Combination with Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)